Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$476M |
| 2 |
Apple
AAPL
|
+$335M |
| 3 |
NVIDIA
NVDA
|
+$316M |
| 4 |
Amazon
AMZN
|
+$175M |
| 5 |
Microsoft
MSFT
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$117M |
| 2 |
Costco
COST
|
+$109M |
| 3 |
Coca-Cola
KO
|
+$103M |
| 4 |
Cisco
CSCO
|
+$90M |
| 5 |
Procter & Gamble
PG
|
+$84.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 18.93% |
| 2 | Healthcare | 17.5% |
| 3 | Technology | 13.05% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
ICU Medical
ICUI
$4.61B
| $496K | ﹤0.01% |
4,624
-17,910
| -79% | -$1.78M |
|
|
SILK
627
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $479K | ﹤0.01% |
+26,144
| New | +$415K |
|
628
Treace Medical Concepts
TMCI
$309M
| $479K | ﹤0.01% |
36,698
+3,178
| +9% | +$42.4K |
|
|
NVRO
629
DELISTED
NEVRO CORP.
NVRO
| $475K | ﹤0.01% |
32,926
-4,907
| -13% | -$81.1K |
|
630
UiPath
PATH
$7.8B
| $472K | ﹤0.01% |
+20,839
| New | +$488K |
|
631
Transmedics
TMDX
$2.91B
| $465K | ﹤0.01% |
6,289
-1,137
| -15% | -$93.7K |
|
632
A.O. Smith
AOS
$8.7B
| $436K | ﹤0.01% |
4,870
-1,363
| -22% | -$112K |
|
633
T. Rowe Price
TROW
$24.3B
| $435K | ﹤0.01% |
3,567
-5
| -0.1% | -$558 |
|
634
HubSpot
HUBS
$10.5B
| $430K | ﹤0.01% |
686
-631
| -48% | -$379K |
|
635
Revvity
RVTY
$12.8B
| $429K | ﹤0.01% |
4,088
-3,111
| -43% | -$331K |
|
636
OrthoPediatrics
KIDS
$595M
| $425K | ﹤0.01% |
14,577
-2,302
| -14% | -$64.4K |
|
637
Boston Properties
BXP
$11.1B
| $423K | ﹤0.01% |
6,480
-15,668
| -71% | -$1.04M |
|
638
Illumina
ILMN
$28.4B
| $412K | ﹤0.01% |
3,087
-2,407
| -44% | -$323K |
|
639
Fulgent Genetics
FLGT
$527M
| $410K | ﹤0.01% |
18,901
-2,911
| -13% | -$72.3K |
|
640
Kilroy Realty
KRC
$4.42B
| $410K | ﹤0.01% |
11,249
-27,970
| -71% | -$1.03M |
|
641
Healthpeak Properties
DOC
$14.8B
| $398K | ﹤0.01% |
21,204
-46,291
| -69% | -$841K |
|
|
EXAS
642
DELISTED
Exact Sciences
EXAS
| $387K | ﹤0.01% |
5,611
-2,720
| -33% | -$172K |
|
643
NeoGenomics
NEO
$2.13B
| $387K | ﹤0.01% |
24,607
-5,226
| -18% | -$80.7K |
|
644
Emerson Electric
EMR
$88.3B
| $387K | ﹤0.01% |
3,410
-37,818
| -92% | -$3.88M |
|
645
Micron Technology
MU
$991B
| $381K | ﹤0.01% |
+3,233
| New | +$293K |
|
646
Edison International
EIX
$26.4B
| $373K | ﹤0.01% |
5,268
-77,622
| -94% | -$5.31M |
|
647
Waters Corp
WAT
$39.9B
| $369K | ﹤0.01% |
1,071
-1,661
| -61% | -$546K |
|
648
The Mosaic Company
MOS
$7.33B
| $359K | ﹤0.01% |
+11,061
| New | +$352K |
|
|
AVNS
649
DELISTED
Avanos Medical
AVNS
| $344K | ﹤0.01% |
17,261
-15,529
| -47% | -$300K |
|
650
Parker-Hannifin
PH
$135B
| $335K | ﹤0.01% |
+602
| New | +$306K |
|
Similar funds
Ray Dalio's Q1 2024 Portfolio in Review
As of Q1 2024, Ray Dalio held 814 positions worth $19.8B, up 11% from $17.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ray Dalio's Q1 2024 filing shows 72 new, 203 increased, 394 reduced and 137 closed positions. Its largest new stake was Amazon: 1,047,891 shares worth $189M. The largest sale was Pinduoduo, an estimated $117M.
By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.
- Ray Dalio's largest Q1 2024 buy was Amazon: 1,047,891 shares worth $189M.
- Ray Dalio added most to Alphabet (Google) Class A in Q1 2024, an estimated $476M increase.
- Ray Dalio's biggest Q1 2024 reduction was Pinduoduo, cutting an estimated $117M.
- Ray Dalio fully exited American Homes 4 Rent in Q1 2024, selling an estimated $21.4M.
- Ray Dalio's ten largest holdings make up 32% of its $19.8B portfolio in Q1 2024.
- Ray Dalio opened 72 new positions and closed 137 in Q1 2024.
- Ray Dalio's portfolio value rose 11% quarter-over-quarter to $19.8B.
Based on Bridgewater Associates's 13F filing for Q1 2024, filed 14 May 2024.